Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers의료 종사자의 BNT162b2 추가 접종 후 면역원성 평가Article Published on 2022-07-262022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] BNT162b2 booster booster vaccination Contact contact with exposure to first vaccination followed by HCW healthcare worker Healthcare workers humoral Humoral response IgA IgA antibodies IgA antibody IgA level IgA levels IgG IgG level IgG levels immune response Immunity immunogenicity implementation increase in Infection Measures new virus pandemic patients Registered restored SARS-COV-2 infection significantly statistically subject the antibody vaccination Vaccine variants virus [DOI] 10.1038/s41598-022-16759-2 PMC 바로가기 [Article Type] Article
Active surveillance and early detection of community transmission of SARS-CoV-2 Mu variant (B.1.621) in the Brazilian Amazon브라질 아마존에서 SARS-CoV-2 Mu 변종(B.1.621) 지역사회 전파에 대한 능동적 감시 및 조기 탐지Article Published on 2022-07-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] Active surveillance All participants Amino acid amino acid substitution Antigen assist Asymptomatic B.1.621 blood sample Blood samples Brazilian Amazon Chain Reaction circulating city collected Community community transmission Contact tracing country COVID-19 patient Diagnosis diagnostic test ELISA testing Emergency epidemiological data followed by genomic genomic sequencing Genomic surveillance highlight household contacts identify IgA IgG IgG levels IgM antibody IgM antibody levels individual infected individual information mild symptoms Mu variant nasopharyngeal swabs one patient ORF1a ORF7a outpatients Participants polymerase chain reaction Porto prospective cohort Rapid diagnostic test reference sequence Reverse transcription-polymerase chain reaction RT-PCR SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants sequenced specimen Surveillance Swab tested Travel variant virus viruses [DOI] 10.1002/jmv.27686 PMC 바로가기 [Article Type] Article
Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: example from an Israeli healthcare worker cohortSARS-CoV-2 anti-S IgG 수준을 이전 감염의 지표로 사용: 이스라엘 의료 종사자 집단의 예Article Published on 2022-07-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] anti-S anti-S IgG level anti-S IgG levels Antigen Chain Reaction Cohort COVID-19 Determining Epidemiology example healthcare worker IgG IgG level IgG levels Infection Israeli healthcare worker marker Negative predictive value polymerase chain polymerase chain reaction Predictive Predictive value public health SARS-CoV-2 SARS-COV-2 infection second dose Serological assay serology Testing threshold vaccination [DOI] 10.1016/j.ijid.2022.04.010 PMC 바로가기 [Article Type] Article
A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primatesResearch article Published on 2022-07-012022-10-05 Journal: Vaccine [Category] 비임상, [키워드] aluminum Antibody Response asked B cell memory boost capsular catalyzed CD4 dose elicited Fever glutaraldehyde IgG IgG level IgG levels IgG response immune immunization IMPROVE induce lack mice NHP non-human primate overcome Phase 1 phosphate polysaccharide polysaccharide vaccine Protein repeated response robust Salmonella serum single dose stimulated subsequent sustained T cell Trial Vaccine vaccine candidate [DOI] 10.1016/j.vaccine.2022.06.043 [Article Type] Research article
Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measuresCOVID-19 비약물적 조치에 따른 가임기 여성의 항보르데텔라 백일해 항체 붕괴Article Published on 2022-06-152022-09-12 Journal: Vaccine [Category] MERS, 백일해, 진단, [키워드] 95% CI Annual Antenatal immunization antibody assigned blood sample Bonferroni correction Bordetella pertussis Canada changed childbearing age collected Coronavirus disease 2019 COVID-19 COVID-19 pandemic decay declined female gestation healthy IgG IgG level IgG levels Immunity Immunoglobulin G implementation incidence Infant Infection Level lowest measure morbidity P-value pertussis Pregnancy pregnant women reduce reflected reported respiratory pathogen sera significantly statistical significance t tests tested transfer women [DOI] 10.1016/j.vaccine.2022.04.086 PMC 바로가기 [Article Type] Article
Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19COVID-19에 대한 2회 접종 불활성 백신에 의한 SARS-CoV-2 감염 및 비감염 의료 종사자의 백신 접종 후 항체 반응의 효능Article Published on 2022-06-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody antibody Antibody Response Antibody responses appearance classical Comorbidities concerning coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection Day demographics detect Efficacy first dose healthcare worker IgG antibodies IgG level IgG levels immunogenicity Immunosuppression inactive individuals infected with SARS-CoV-2 Infection information investigated majority Neutralizing activity positive postvaccination produced rapid increase SARS-CoV-2 screened second dose second vaccination seropositive seropositive individual seropositive individuals Seropositivity significantly higher Sinovac subject subjects Support Symptoms titers vaccination Vaccine virus [DOI] 10.1002/jmv.27649 PMC 바로가기 [Article Type] Article
SARS-CoV-2 infections in mRNA vaccinated individuals are biased for viruses encoding spike E484K and associated with reduced infectious virus loads that correlate with respiratory antiviral IgG levelsmRNA 백신을 접종한 개인의 SARS-CoV-2 감염은 스파이크 E484K를 인코딩하는 바이러스에 대해 편향되어 있으며 호흡기 항바이러스성 IgG 수준과 상관관계가 있는 감소된 감염성 바이러스 부하와 관련이 있습니다.Article Published on 2022-06-012022-09-11 Journal: Journal of Clinical Virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료제, [키워드] A significant reduction accompanied Alpha Alpha variant Amino acid Analysis Anti-viral Antiviral association B.1.1.7 B.1.526 BNT162b2 Breakthrough infection breakthrough infections caused Cell culture change Cohort collected COVID-19 cycle threshold dose E484K early phase ELISA examined Genome ICU admission IgG IgG level IgG levels immunization increase in Infectious virus investigated Lineage Moderna molecular Mortality mRNA mRNA-1273 PCR Pfizer-BioNTech positive positive sample Positive test predominant Protein reduce reduced required respiratory respiratory sample Respiratory samples Sample SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-COV-2 infection SARS-CoV-2 positive patient sequenced Sequencing specimen specimens spike Spike protein symptomatic infection symptomatic infections upper respiratory tract vaccinated individual vaccinated individuals vaccination Vaccines variant Viral Viral load viral loads viral variant virus were used whole genome [DOI] 10.1016/j.jcv.2022.105151 PMC 바로가기 [Article Type] Article
Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks수용체 결합 도메인-IgG 수준은 SARS-CoV-2 B.1.1.7 발병에 직면한 거주자의 보호와 상관관계가 있습니다.Article Published on 2022-06-012022-09-11 Journal: Allergy [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료법, [키워드] antibody Antibody Response antigenemia association B.1.1.7 binding BNT162b2 BNT162b2 vaccine Chain Reaction COVID-19 death domain dose Efficacy humoral IgG levels in vitro incidence information Limited Nasopharyngeal swab nasopharyngeal swab test Neutralizing Neutralizing antibodies nucleocapsid nucleocapsid antigenemia nursing home nursing homes outbreak polymerase chain polymerase chain reaction positive Post-vaccine qPCR RBD reduction residents reverse-transcriptase polymerase chain reaction risk risk factor RT-qPCR S1 subunit SARS-CoV-2 SARS-CoV-2 B.1.1.7 Serum Neutralization Serum neutralizing antibody Seven severe COVID-19 severe symptoms Symptom Symptoms tested the S1 subunit Vaccine was measured [DOI] 10.1111/all.15142 PMC 바로가기 [Article Type] Article
Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis항-CD20 치료 다발성 경화증에서 SARS-CoV-2에 대한 보존된 T 세포 반응Article Published on 2022-06-012022-09-11 Journal: Multiple sclerosis (Houndmills, Basingstoke, Engla [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 anti-CD20 anti-CD20 therapy anti-SARS-CoV-2 anti-SARS-CoV-2 spike protein antibodies Antibody avidity avidity CD20 Cellular immune response Cohort Coronavirus-2 detectable healthy control healthy controls humoral Humoral and cellular immune responses IgA IgG IgG level IgG levels immune responses Immunoglobulin Immunoglobulin G infected with SARS-CoV-2 management Multiple multiple sclerosis neutralizing capacity occurred pandemic Patient respiratory SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 spike protein SARS-CoV-2 vaccination SARS-CoV-2-specific T cell SARS-CoV-2-specific T cells second vaccination Spike protein T cell response T cells treated Treatment vaccination Vaccinations virus were measured [DOI] 10.1177/13524585221094478 PMC 바로가기 [Article Type] Article
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects다발성 경화증 환자에서 SARS-CoV-2 체액 반응의 장기간 지속Article Published on 2022-06-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus age anti-Spike IgG anti-spike IgG levels appearance benefit BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine BNT162b2-mRNA vaccine booster booster vaccination booster vaccinations Cladribine Cohort comparable coronavirus Coronavirus-19 dimethyl fumarate Disease modifying therapies dose eight evaluated faster fingolimod Fingolimod- Glatiramer Glatiramer acetate groups healthy control healthy controls humoral humoral immune response Humoral persistence Humoral response IgG IgG levels interferon long term mRNA vaccine Multiple multiple sclerosis Natalizumab Ocrelizumab pandemic Patient patients persistence receiving regimen respiratory SARS-CoV-2 SARS-CoV-2 BNT162b2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 spike protein severe acute respiratory syndrome Coronavirus spike Spike protein subject subjects Teriflunomide the SARS-CoV-2 titre variants [DOI] 10.1016/j.msard.2022.103800 PMC 바로가기 [Article Type] Article